Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
• The global Biotechnological Drugs market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Biotechnological Drugs market is expected to reach the value of US$ XX Million by the end of 2031
Biotechnological Drugs Market Overview
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies and analyses global Biotechnological Drugs status and future trends, helping the client to determine the Biotechnological Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biotechnological Drugs. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Biotechnological Drugs Market Key Takeaways
(1) Global Biotechnological Drugs market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Biotechnological Drugs sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Biotechnological Drugs sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Biotechnological Drugs key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Biotechnological Drugs key producing regions, capacity, production, and year-over-year growth
(6) Biotechnological Drugs industry chains, upstream, midstream, and downstream
Biotechnological Drugs Market: Key Players
The competitive landscape of the Biotechnological Drugs Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Biotechnological Drugs Market. Some of the major players operating in the Biotechnological Drugs Market are:
- 3SBIO
- Anhui Anke Biotechnology
- Beijing SL Pharmaceutical
- Biotech Pharmaceutical
- Cadila Healthcare
- Celgen Biopharma
- Celltrion
- Dr Reddy’s
- GeneScience Pharmaceuticals
- Hisun Pharma
- Jiangsu Sihuan Bioengineering
- Novartis (Sandoz)
- Pfizer (Hospira)
- Shanghai Lansheng Guojian Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Tonghua Dongbao Pharmaceutical
- Torrent Pharmaceuticals
Market IntelliX's study on the Biotechnological Drugs market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Biotechnological Drugs Market by Type [Analysis by Value from 2020 to 2031]:
- Genetically Engineered Drugs
- Therapeutic Monoclonal Antibody Drugs
- Gene Therapy and Nucleic Acid Drugs
- Genetically Engineered Vaccines
- Other
Biotechnological Drugs Market by Application [Analysis by Value from 2020 to 2031]:
- Tumor
- Autoimmune Disease
- Other
Biotechnological Drugs Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America (Brazil, Argentina and Colombia etc.)
- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Biotechnological Drugs Market Report Includes:
Chapter 1: To describe Biotechnological Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Biotechnological Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 3: China Biotechnological Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 4: Global key producing regions of Biotechnological Drugs , percent & CAGR, 2020 - 2031
Chapter 5: Biotechnological Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Biotechnological Drugs Definition
1.2 Global Biotechnological Drugs Market Size and Forecast
1.3 China Biotechnological Drugs Market Size and Forecast
1.4 Share of China Biotechnological Drugs Market with Respect to the Global Market
1.5 Biotechnological Drugs Market Size: China VS Global Growth Rate, 2020-2031
1.6 Biotechnological Drugs Market Dynamics
1.6.1 Biotechnological Drugs Market Drivers
1.6.2 Biotechnological Drugs Market Restraints
1.6.3 Biotechnological Drugs Industry Trends
1.6.4 Biotechnological Drugs Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Biotechnological Drugs, Global Market Share by Company, 2020-2025
2.2 Global Biotechnological Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biotechnological Drugs Concentration Ratio
2.4 Global Biotechnological Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Biotechnological Drugs Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Biotechnological Drugs, China Market Share by Company, 2020-2025
3.2 China Biotechnological Drugs Biotechnological Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Biotechnological Drugs Industry Chain
4.2 Biotechnological Drugs Upstream Analysis
4.2.1 Biotechnological Drugs Core Raw Materials
4.2.2 Main Manufacturers of Biotechnological Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Biotechnological Drugs Production Mode
4.6 Biotechnological Drugs Procurement Model
4.7 Biotechnological Drugs Industry Sales Model and Sales Channels
4.7.1 Biotechnological Drugs Sales Model
4.7.2 Biotechnological Drugs Typical Distributors
5 Sights by Type
5.1 Biotechnological Drugs Classification
5.1.1 Genetically Engineered Drugs
5.1.2 Therapeutic Monoclonal Antibody Drugs
5.1.3 Gene Therapy and Nucleic Acid Drugs
5.1.4 Genetically Engineered Vaccines
5.1.5 Other
5.2 by Type, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Biotechnological Drugs Consumption Value, 2020-2031
6 Sights by Application
6.1 Biotechnological Drugs Segment by Application
6.1.1 Tumor
6.1.2 Autoimmune Disease
6.1.3 Other
6.2 by Application, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Biotechnological Drugs Consumption Value, 2020-2031
7 Sales Sights by Region
7.1 By Region, Global Biotechnological Drugs Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Biotechnological Drugs Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Biotechnological Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Biotechnological Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Biotechnological Drugs Market Size Market Share
7.6 South America
7.6.1 South AmericaBiotechnological Drugs Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Biotechnological Drugs Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Biotechnological Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Biotechnological Drugs Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Biotechnological Drugs Market Size, 2020-2031
8.3.2 by Type, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Biotechnological Drugs Market Size, 2020-2031
8.4.2 by Type, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Biotechnological Drugs Market Size, 2020-2031
8.5.2 by Type, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Biotechnological Drugs Market Size, 2020-2031
8.6.2 by Type, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Biotechnological Drugs Market Size, 2020-2031
8.7.2 by Type, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Biotechnological Drugs Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Biotechnological Drugs Market Size, 2020-2031
8.9.2 by Type, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Biotechnological Drugs Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
9 Company Profile
9.1 3SBIO
9.1.1 3SBIO Company Information, Head Office, Market Area, and Industry Position
9.1.2 3SBIO Company Profile and Main Business
9.1.3 3SBIO Biotechnological Drugs Models, Specifications, and Application
9.1.4 3SBIO Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.1.5 3SBIO Recent Developments
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.2.2 Anhui Anke Biotechnology Company Profile and Main Business
9.2.3 Anhui Anke Biotechnology Biotechnological Drugs Models, Specifications, and Application
9.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.2.5 Anhui Anke Biotechnology Recent Developments
9.3 Beijing SL Pharmaceutical
9.3.1 Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.3.2 Beijing SL Pharmaceutical Company Profile and Main Business
9.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.3.5 Beijing SL Pharmaceutical Recent Developments
9.4 Biotech Pharmaceutical
9.4.1 Biotech Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.4.2 Biotech Pharmaceutical Company Profile and Main Business
9.4.3 Biotech Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.4.5 Biotech Pharmaceutical Recent Developments
9.5 Cadila Healthcare
9.5.1 Cadila Healthcare Company Information, Head Office, Market Area, and Industry Position
9.5.2 Cadila Healthcare Company Profile and Main Business
9.5.3 Cadila Healthcare Biotechnological Drugs Models, Specifications, and Application
9.5.4 Cadila Healthcare Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.5.5 Cadila Healthcare Recent Developments
9.6 Celgen Biopharma
9.6.1 Celgen Biopharma Company Information, Head Office, Market Area, and Industry Position
9.6.2 Celgen Biopharma Company Profile and Main Business
9.6.3 Celgen Biopharma Biotechnological Drugs Models, Specifications, and Application
9.6.4 Celgen Biopharma Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.6.5 Celgen Biopharma Recent Developments
9.7 Celltrion
9.7.1 Celltrion Company Information, Head Office, Market Area, and Industry Position
9.7.2 Celltrion Company Profile and Main Business
9.7.3 Celltrion Biotechnological Drugs Models, Specifications, and Application
9.7.4 Celltrion Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.7.5 Celltrion Recent Developments
9.8 Dr Reddy’s
9.8.1 Dr Reddy’s Company Information, Head Office, Market Area, and Industry Position
9.8.2 Dr Reddy’s Company Profile and Main Business
9.8.3 Dr Reddy’s Biotechnological Drugs Models, Specifications, and Application
9.8.4 Dr Reddy’s Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.8.5 Dr Reddy’s Recent Developments
9.9 GeneScience Pharmaceuticals
9.9.1 GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
9.9.2 GeneScience Pharmaceuticals Company Profile and Main Business
9.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
9.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.9.5 GeneScience Pharmaceuticals Recent Developments
9.10 Hisun Pharma
9.10.1 Hisun Pharma Company Information, Head Office, Market Area, and Industry Position
9.10.2 Hisun Pharma Company Profile and Main Business
9.10.3 Hisun Pharma Biotechnological Drugs Models, Specifications, and Application
9.10.4 Hisun Pharma Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.10.5 Hisun Pharma Recent Developments
9.11 Jiangsu Sihuan Bioengineering
9.11.1 Jiangsu Sihuan Bioengineering Company Information, Head Office, Market Area, and Industry Position
9.11.2 Jiangsu Sihuan Bioengineering Company Profile and Main Business
9.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Models, Specifications, and Application
9.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.11.5 Jiangsu Sihuan Bioengineering Recent Developments
9.12 Novartis (Sandoz)
9.12.1 Novartis (Sandoz) Company Information, Head Office, Market Area, and Industry Position
9.12.2 Novartis (Sandoz) Company Profile and Main Business
9.12.3 Novartis (Sandoz) Biotechnological Drugs Models, Specifications, and Application
9.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.12.5 Novartis (Sandoz) Recent Developments
9.13 Pfizer (Hospira)
9.13.1 Pfizer (Hospira) Company Information, Head Office, Market Area, and Industry Position
9.13.2 Pfizer (Hospira) Company Profile and Main Business
9.13.3 Pfizer (Hospira) Biotechnological Drugs Models, Specifications, and Application
9.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.13.5 Pfizer (Hospira) Recent Developments
9.14 Shanghai Lansheng Guojian Pharmaceutical
9.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.14.2 Shanghai Lansheng Guojian Pharmaceutical Company Profile and Main Business
9.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
9.15 Shenzhen Neptunus Interlong Bio-Technique
9.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, Market Area, and Industry Position
9.15.2 Shenzhen Neptunus Interlong Bio-Technique Company Profile and Main Business
9.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Models, Specifications, and Application
9.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
9.16 Tonghua Dongbao Pharmaceutical
9.16.1 Tonghua Dongbao Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.16.2 Tonghua Dongbao Pharmaceutical Company Profile and Main Business
9.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
9.17 Torrent Pharmaceuticals
9.17.1 Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
9.17.2 Torrent Pharmaceuticals Company Profile and Main Business
9.17.3 Torrent Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
9.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.17.5 Torrent Pharmaceuticals Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Biotechnological Drugs Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Biotechnological Drugs Market Restraints
Table 3. Biotechnological Drugs Market Trends
Table 4. Biotechnological Drugs Industry Policy
Table 5. Global Biotechnological Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Biotechnological Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biotechnological Drugs Mergers & Acquisitions, Expansion Plans
Table 9. Global Biotechnological Drugs Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Biotechnological Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 12. China Biotechnological Drugs Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Biotechnological Drugs Upstream (Raw Materials)
Table 14. Global Biotechnological Drugs Typical Customers
Table 15. Biotechnological Drugs Typical Distributors
Table 16. by Type, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. by Application, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Biotechnological Drugs Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 19. By Region, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Table 20. By Country, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Table 22. By Country, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Table 23. 3SBIO Company Information, Head Office, Market Area, and Industry Position
Table 24. 3SBIO Company Profile and Main Business
Table 25. 3SBIO Biotechnological Drugs Models, Specifications, and Application
Table 26. 3SBIO Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 27. 3SBIO Recent Developments
Table 28. Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 29. Anhui Anke Biotechnology Company Profile and Main Business
Table 30. Anhui Anke Biotechnology Biotechnological Drugs Models, Specifications, and Application
Table 31. Anhui Anke Biotechnology Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 32. Anhui Anke Biotechnology Recent Developments
Table 33. Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 34. Beijing SL Pharmaceutical Company Profile and Main Business
Table 35. Beijing SL Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 36. Beijing SL Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 37. Beijing SL Pharmaceutical Recent Developments
Table 38. Biotech Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 39. Biotech Pharmaceutical Company Profile and Main Business
Table 40. Biotech Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 41. Biotech Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 42. Biotech Pharmaceutical Recent Developments
Table 43. Cadila Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 44. Cadila Healthcare Company Profile and Main Business
Table 45. Cadila Healthcare Biotechnological Drugs Models, Specifications, and Application
Table 46. Cadila Healthcare Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 47. Cadila Healthcare Recent Developments
Table 48. Celgen Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 49. Celgen Biopharma Company Profile and Main Business
Table 50. Celgen Biopharma Biotechnological Drugs Models, Specifications, and Application
Table 51. Celgen Biopharma Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 52. Celgen Biopharma Recent Developments
Table 53. Celltrion Company Information, Head Office, Market Area, and Industry Position
Table 54. Celltrion Company Profile and Main Business
Table 55. Celltrion Biotechnological Drugs Models, Specifications, and Application
Table 56. Celltrion Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 57. Celltrion Recent Developments
Table 58. Dr Reddy’s Company Information, Head Office, Market Area, and Industry Position
Table 59. Dr Reddy’s Company Profile and Main Business
Table 60. Dr Reddy’s Biotechnological Drugs Models, Specifications, and Application
Table 61. Dr Reddy’s Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 62. Dr Reddy’s Recent Developments
Table 63. GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 64. GeneScience Pharmaceuticals Company Profile and Main Business
Table 65. GeneScience Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
Table 66. GeneScience Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 67. GeneScience Pharmaceuticals Recent Developments
Table 68. Hisun Pharma Company Information, Head Office, Market Area, and Industry Position
Table 69. Hisun Pharma Company Profile and Main Business
Table 70. Hisun Pharma Biotechnological Drugs Models, Specifications, and Application
Table 71. Hisun Pharma Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 72. Hisun Pharma Recent Developments
Table 73. Jiangsu Sihuan Bioengineering Company Information, Head Office, Market Area, and Industry Position
Table 74. Jiangsu Sihuan Bioengineering Company Profile and Main Business
Table 75. Jiangsu Sihuan Bioengineering Biotechnological Drugs Models, Specifications, and Application
Table 76. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 77. Jiangsu Sihuan Bioengineering Recent Developments
Table 78. Novartis (Sandoz) Company Information, Head Office, Market Area, and Industry Position
Table 79. Novartis (Sandoz) Company Profile and Main Business
Table 80. Novartis (Sandoz) Biotechnological Drugs Models, Specifications, and Application
Table 81. Novartis (Sandoz) Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 82. Novartis (Sandoz) Recent Developments
Table 83. Pfizer (Hospira) Company Information, Head Office, Market Area, and Industry Position
Table 84. Pfizer (Hospira) Company Profile and Main Business
Table 85. Pfizer (Hospira) Biotechnological Drugs Models, Specifications, and Application
Table 86. Pfizer (Hospira) Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 87. Pfizer (Hospira) Recent Developments
Table 88. Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 89. Shanghai Lansheng Guojian Pharmaceutical Company Profile and Main Business
Table 90. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 91. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 92. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 93. Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, Market Area, and Industry Position
Table 94. Shenzhen Neptunus Interlong Bio-Technique Company Profile and Main Business
Table 95. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Models, Specifications, and Application
Table 96. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 97. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 98. Tonghua Dongbao Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 99. Tonghua Dongbao Pharmaceutical Company Profile and Main Business
Table 100. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 101. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 102. Tonghua Dongbao Pharmaceutical Recent Developments
Table 103. Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 104. Torrent Pharmaceuticals Company Profile and Main Business
Table 105. Torrent Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
Table 106. Torrent Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 107. Torrent Pharmaceuticals Recent Developments
List of Figures
Figure 1. Biotechnological Drugs Picture
Figure 2. Global Biotechnological Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 3. China Biotechnological Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 4. By Consumption Value, China Biotechnological Drugs Market Share of Global, 2020-2031
Figure 5. Global Biotechnological Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 6. China Biotechnological Drugs Key Participants, Market Share, 2024
Figure 7. Biotechnological Drugs Industry Chain
Figure 8. Biotechnological Drugs Procurement Model
Figure 9. Biotechnological Drugs Sales Model
Figure 10. Biotechnological Drugs Sales Channels, Direct Sales, and Distribution
Figure 11. Genetically Engineered Drugs
Figure 12. Therapeutic Monoclonal Antibody Drugs
Figure 13. Gene Therapy and Nucleic Acid Drugs
Figure 14. Genetically Engineered Vaccines
Figure 15. Other
Figure 16. by Type, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 17. by Type, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Figure 18. Tumor
Figure 19. Autoimmune Disease
Figure 20. Other
Figure 21. by Application, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 22. by Application, Global Biotechnological Drugs Revenue Market Share, 2020-2031
Figure 23. By Region, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Figure 24. North America Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 25. By Country, North America Biotechnological Drugs Consumption Value Market Share, 2024
Figure 26. Europe Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 27. By Country, Europe Biotechnological Drugs Consumption Value Market Share, 2024
Figure 28. Asia Pacific Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 29. By Country/Region, Asia Pacific Biotechnological Drugs Consumption Value Market Share, 2024
Figure 30. South America Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 31. By Country, South America Biotechnological Drugs Consumption Value Market Share, 2024
Figure 32. Middle East & Africa Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 33. United States Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 34. by Type, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 35. by Application, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 36. Europe Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 37. by Type, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 38. by Application, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 39. China Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 40. by Type, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 41. by Application, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 42. Japan Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 43. by Type, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 44. by Application, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 45. South Korea Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 46. by Type, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 47. by Application, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 48. Southeast Asia Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 49. by Type, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 50. by Application, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 51. India Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 52. by Type, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 53. by Application, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 54. Middle East & Africa Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 55. by Type, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 56. by Application, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 57. Research Methodology
Figure 58. Breakdown of Primary Interviews
Figure 59. Bottom-up Approaches
Figure 60. Top-down Approaches
Research Methodology:
Biotechnological Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|